Context Therapeutics Inc (CNTX)
2.15
+0.01
(+0.47%)
USD |
NASDAQ |
Jun 25, 16:00
2.15
0.00 (0.00%)
After-Hours: 19:21
Context Therapeutics Net Income (Quarterly): -3.668M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.668M |
| December 31, 2023 | -6.770M |
| September 30, 2023 | -5.875M |
| June 30, 2023 | -5.011M |
| March 31, 2023 | -6.308M |
| December 31, 2022 | -3.557M |
| September 30, 2022 | -3.854M |
| June 30, 2022 | -3.986M |
| March 31, 2022 | -3.438M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.092M |
| September 30, 2021 | -1.443M |
| June 30, 2021 | -5.030M |
| March 31, 2021 | -0.892M |
| December 31, 2020 | -0.7847M |
| September 30, 2020 | -0.8762M |
| June 30, 2020 | 7.479M |
| March 31, 2020 | 0.8265M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-6.770M
Minimum
Dec 2023
7.479M
Maximum
Jun 2020
-2.722M
Average
-3.557M
Median
Dec 2022
Net Income (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 9.00M |
| AbbVie Inc | 1.369B |
| Revance Therapeutics Inc | -53.15M |
| Design Therapeutics Inc | -11.10M |
| NovaBay Pharmaceuticals Inc | -3.214M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.824M |
| EPS Diluted (Quarterly) | -0.23 |
| Enterprise Value | 150.41M |
| Earnings Yield | -61.86% |